Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx — Stella

Recruiting

Back to Oropharynx Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Duke University Medical Center, Durham, North Carolina

Duke Raleigh Hospital, Raleigh, North Carolina

Key details

Sponsor

Duke University

Enrollment target

~120 participants

Started

April 2021

Primary completion

January 2028

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov